These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
399 related articles for article (PubMed ID: 11927396)
1. Atrial natriuretic factor and C-type natriuretic peptide induce retraction of human thyrocytes in monolayer culture via guanylyl cyclase receptors. Sellitti DF; Lagranha C; Perrella G; Curcio F; Doi SQ J Endocrinol; 2002 Apr; 173(1):169-76. PubMed ID: 11927396 [TBL] [Abstract][Full Text] [Related]
2. cAMP inhibits natriuretic peptide receptor-B activity and increases C-type natriuretic peptide in FRTL-5 rat thyroid cells. Sellitti DF; Puggina E; Lagranha C; Doi SQ J Endocrinol; 2004 Jan; 180(1):23-34. PubMed ID: 14709141 [TBL] [Abstract][Full Text] [Related]
3. The receptor attributable to C-type natriuretic peptide-induced differentiation of osteoblasts is switched from type B- to type C-natriuretic peptide receptor with aging. Kaneki H; Kurokawa M; Ide H J Cell Biochem; 2008 Feb; 103(3):753-64. PubMed ID: 17562543 [TBL] [Abstract][Full Text] [Related]
4. Natriuretic peptides increase cAMP production in human thyrocytes via the natriuretic peptide clearance receptor (NPR-C). Sellitti DF; Perrella G; Doi SQ; Curcio F Regul Pept; 2001 Mar; 97(2-3):103-9. PubMed ID: 11164945 [TBL] [Abstract][Full Text] [Related]
5. Regulation of natriuretic peptide receptors by thyrotropin in FRTL-5 rat thyroid cells: evidence for nonguanylate cyclase atrial natriuretic factor-binding sites in cells lacking the natriuretic peptide receptor C. Sellitti DF; Doi SQ Endocrinology; 1999 Mar; 140(3):1365-74. PubMed ID: 10067864 [TBL] [Abstract][Full Text] [Related]
6. C-type natriuretic Peptide down-regulates expression of its cognate receptor in rat aortic smooth muscle cells. Rahmutula D; Gardner DG Endocrinology; 2005 Nov; 146(11):4968-74. PubMed ID: 16109786 [TBL] [Abstract][Full Text] [Related]
7. Differential regulation of natriuretic peptide receptors on ciliary body epithelial cells. Crook RB; Chang AT Biochem J; 1997 May; 324 ( Pt 1)(Pt 1):49-55. PubMed ID: 9164840 [TBL] [Abstract][Full Text] [Related]
8. Cyclic adenosine monophosphate (cAMP) increases natriuretic peptide receptor C (NPR-C) expression in human aortic smooth muscle cells. Puggina E; Sellitti D Mol Cell Endocrinol; 2004 Apr; 219(1-2):161-9. PubMed ID: 15149737 [TBL] [Abstract][Full Text] [Related]
9. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Nir A; Zhang DF; Fixler R; Burnett JC; Eilam Y; Hasin Y Eur J Pharmacol; 2001 Feb; 412(3):195-201. PubMed ID: 11166282 [TBL] [Abstract][Full Text] [Related]
10. C-type natriuretic peptide inhibits ANP secretion and atrial dynamics in perfused atria: NPR-B-cGMP signaling. Lee SJ; Kim SZ; Cui X; Kim SH; Lee KS; Chung YJ; Cho KW Am J Physiol Heart Circ Physiol; 2000 Jan; 278(1):H208-21. PubMed ID: 10644601 [TBL] [Abstract][Full Text] [Related]
11. Specific potentiation by cyclic AMP of natriuretic peptide-mediated cyclic GMP production in adipose tissue. Thibault G; Lacasse A; Garcia R Life Sci; 1996; 58(25):2345-53. PubMed ID: 8649224 [TBL] [Abstract][Full Text] [Related]
12. C-type natriuretic peptide as a podocyte hormone and modulation of its cGMP production by glucose and mechanical stress. Lewko B; Endlich N; Kriz W; Stepinski J; Endlich K Kidney Int; 2004 Sep; 66(3):1001-8. PubMed ID: 15327393 [TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid inhibits C-type natriuretic peptide activation of guanylyl cyclase-B. Abbey SE; Potter LR Endocrinology; 2003 Jan; 144(1):240-6. PubMed ID: 12488350 [TBL] [Abstract][Full Text] [Related]
14. Differential expression and synthesis of natriuretic peptides determines natriuretic peptide receptor expression in primary cultures of human proximal tubular cells. Mistry SK; Hawksworth GM; Struthers AD; McLay JS J Hypertens; 2001 Feb; 19(2):255-62. PubMed ID: 11212968 [TBL] [Abstract][Full Text] [Related]
15. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling. Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708 [TBL] [Abstract][Full Text] [Related]
16. Signaling and distribution of NPR-Bi, the human splice form of the natriuretic peptide receptor type B. Hirsch JR; Skutta N; Schlatter E Am J Physiol Renal Physiol; 2003 Aug; 285(2):F370-4. PubMed ID: 12709393 [TBL] [Abstract][Full Text] [Related]
17. Sphingosine-1-phosphate inhibits C-type natriuretic peptide activation of guanylyl cyclase B (GC-B/NPR-B). Abbey-Hosch SE; Cody AN; Potter LR Hypertension; 2004 May; 43(5):1103-9. PubMed ID: 15037564 [TBL] [Abstract][Full Text] [Related]